(Q38014580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Mathew Upton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Mohammed M Al-Mahrous

series ordinal

1

1 reference

27 August 2017

Mathew Upton

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

18 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Discovery

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

155-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

Antibacterial drug discovery: is it all downhill from here?

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Antibacterial drug discovery in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

The abandonment of antibacterials: why and wherefore?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Antibiotics: where did we go wrong?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Lipid II as a target for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Bacterial lantibiotics: strategies to improve therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Lantibiotics: peptides of diverse structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

The dawning of a 'Golden era' in lantibiotic bioengineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

SapT, a lanthionine-containing peptide involved in aerial hyphae formation in the streptomycetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Biosynthesis and biological activities of lantibiotics with unique post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

The genetics of lantibiotic biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Elucidation of the Primary Structure of the Lantibiotic Epilancin K7 from Staphylococcus epidermidis K7. Cloning and Characterisation of the Epilancin-K7-Encoding Gene and NMR Analysis of Mature Epilancin K7

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Distributive and directional behavior of lantibiotic synthetases revealed by high-resolution tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Analysis of genes involved in the biosynthesis of lantibiotic epidermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Structure of the pheromone peptide of the Staphylococcus epidermidis agr system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

BAGEL2: mining for bacteriocins in genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

NisB is required for the dehydration and NisC for the lanthionine formation in the post-translational modification of nisin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Multiple activities in lantibiotics--models for the design of novel antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Biochemistry. Five golden rings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Complete genome sequence of an M1 strain of Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Purification and Characterization of Streptin, a Type A1 Lantibiotic Produced by Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

The codon usage of the nisZ operon in Lactococcus lactis N8 suggests a non-lactococcal origin of the conjugative nisin-sucrose transposon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

The complete genome sequence of the gram-positive bacterium Bacillus subtilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

New gene cluster for lantibiotic streptin possibly involved in streptolysin S formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Biosynthesis of peptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Signal peptides: exquisitely designed transport promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Substrate analogues to study cell-wall biosynthesis and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Additional antibiotic inhibitors of peptidoglycan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Inhibition of Bacillus anthracis spore outgrowth by nisin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Insights into the mode of action of the two-peptide lantibiotic haloduracin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Drug discovery and natural products: end of an era or an endless frontier?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Using expressed protein ligation to probe the substrate specificity of lantibiotic synthetases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Applications of the bacteriocin, nisin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Purification and characterization of a novel delta-lysin variant that inhibits Staphylococcus aureus and has limited hemolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Cationic peptides: effectors in innate immunity and novel antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Self-Assembled Plasmonic Nanoparticle Clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.545387

Rapid and Efficient Purification Method for Small, Hydrophobic, Cationic Bacteriocins: Purification of Lactococcin B and Pediocin PA-1.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1128/AEM.63.1.305-309.1997

Identifiers

DOI

10.1517/17460441.2011.545387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22647134%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference